Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Parovarian tumors of borderline malignancy
M. J. Song1, C. W. Lee1, E. K. Park2, A. W. Lee3, J. S. Park1, S. Y. Hur1,*
1 Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul;
2 Department of Obstetrics and Gynecology, Dae Jeon St. Mary’s Hospital, The Catholic University of Korea, Seoul;
3 Department of Pathology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul (Korea)
Eur. J. Gynaecol. Oncol. 2011, 32(4), 445–447;
Published: 10 August 2011
The incidence of a parovarian tumor is 10-20% of all uterine adnexal masses, however, it is benign in most cases, and a borderline or malignant tumor is extremely rare. The classification of disease stage and treatment is still controversial owing to its scarcity. We have managed one mucinous and two serous cystadenomas of borderline malignancy originating from paraovarian cysts inour institute over ten year. We report and discuss the cases herein.